Please login to the form below

Not currently logged in
Email:
Password:

Ono Pharmaceutical

This page shows the latest Ono Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

Merck settles PD-1 patent lawsuit with BMS and Ono

Merck settles PD-1 patent lawsuit with BMS and Ono

The US drugmaker has agreed to pay Bristol-Myers Squibb and Ono Pharmaceutical $625m to settle the patent infringement litigation - focusing on intellectual property in the area of PD-1 inhibitors - ... The initial payment and royalties will be shared

Latest news

More from news
Approximately 4 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Clearly on a roll with Japan, X-Chem has also signed a deal with Ono Pharmaceutical covering oncology targets. ... 190. Ambest Pharmaceutical. Sihuan Pharmaceutical. Acquisition. Manufacturing of injectables. 160. X-Chem.

  • Deal Watch July 2016 Deal Watch July 2016

    In the second immuno-therapy deal to make the top 20 this month ONO Pharmaceuticals paid $12.5m upfront for the rights to develop Celyad's phase I product, allogeneic ... Acquisition. 325. Celyad/ ONO Pharmaceutical. Allogeneic NKR-2 T-cell immunotherapy.

  • Pharma deals during July 2014 Pharma deals during July 2014

    Existing partners Bristol-Myers Squibb (BMS) and Ono Pharmaceutical also announced that they will jointly develop and commercialise multiple immunotherapies as single and combination treatments. In this collaboration the focus is

  • Pharma deals during August 2013 Pharma deals during August 2013

    Onyx has sole marketing rights with the exception of Japan where it is licensed to Ono Pharmaceutical. ... Thornton &Ross.Thornton &Ross is one of the fastest growing companies in the UK pharmaceutical market (11 per cent sales growth over the previous

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics